Monopar Therapeutics
MNPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645469
In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 4 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Monopar Therapeutics changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 82 | +9 |
| Shares | 5.53M | 293.8K | 6.24M | +1.00M (+19.2%) |
| Value | $360.8M | $19.2M | $341.5M | −$64.2K (0.0%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Monopar Therapeutics at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 218,463 | $12.0M | 0.00% |
| Sio Capital Management, LLC | 173,506 | $9.51M | 1.37% |
| Vestal Point Capital, LP | 65,418 | $3.58M | 0.10% |
| Walleye Capital LLC | 63,119 | $3.46M | 0.02% |
| Vanguard Portfolio Management LLC | 45,987 | $2.52M | 0.00% |
| Silverarc Capital Management, LLC | 43,488 | $2.38M | 0.28% |
| Vanguard Fiduciary Trust Co | 28,447 | $1.56M | 0.00% |
| Jump Financial, LLC | 22,808 | $1.25M | 0.02% |
| Winton Group Ltd | 6,829 | $374.2K | 0.01% |
| Ameriprise Financial Inc | 6,819 | $373.6K | 0.00% |
| Creative Planning | 5,987 | $328.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 4,572 | $250.5K | 0.00% |
| Susquehanna International Group, LLP | 4,137 | $226.7K | 0.00% |
| Quadrature Capital Ltd | 3,673 | $201.2K | 0.00% |
| Your Advocates Ltd., LLP | 3,344 | $183.2K | 0.06% |
| Diadema Partners LP | 1,630 | $89.3K | 0.04% |
| Vanguard Global Advisers, LLC | 1,553 | $85.1K | 0.00% |
| Persistent Asset Partners Ltd | 783 | $42.9K | 0.02% |
| US Bancorp | 72 | $3.94K | 0.00% |
| Kilter Group LLC | 1 | $55 | 0.00% |
Sold out (11)
Institutions that held Monopar Therapeutics at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Deep Track Capital, LP | 95,408 | $6.23M |
| Renaissance Technologies LLC | 11,431 | $746.4K |
| Virtu Financial LLC | 10,009 | $654.0K |
| Mountain Pacific Investment Advisers Inc | 6,100 | $398.3K |
| State of Wisconsin Investment Board | 5,757 | $375.9K |
| BankChampaign, National Association | 4,510 | $294.5K |
| Trexquant Investment LP | 3,778 | $246.7K |
| Invesco Ltd. | 3,355 | $219.1K |
| Quest Partners LLC | 1,983 | $129.5K |
| Canada Pension Plan Investment Board | 1,400 | $91.4K |
| Amalgamated Bank | 144 | $9.00K |
Not filed for Q1 2026 yet (1)
Institutions that held Monopar Therapeutics at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 293,816 | $19.2M |